title: Characterization of volume-activated chloride currents in regulatory volume decrease of human cholangiocyte.
abstract: Volume-activated chloride channel (VACC) plays vital roles in many physiological functions. In bile duct epithelium, VACC actively participates in biliary secretion and cell volume regulation, and it mediates regulatory volume decrease (RVD). Recently, we have shown that mouse cholangiocytes have an intact RVD via VACC and K(+) conductance. However, such cell volume regulation was not studied in the normal human cholangiocyte. Volume measurement by Coulter counter and whole-cell patch clamp technique were used to characterize the RVD and VACC in human cholangiocyte cell line (HBDC). When exposed to hypotonic solution, HBDC exhibited an intact RVD, which was inhibited by 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM), NPPB (5-nitro-2'- (3-phenylpropylamino)-benzoate), DIDS (4,4'-diisothiocyanatostilbene-2-disulfonic acid), and tamoxifen, but was not affected by the removal of extracellular calcium. During RVD, HBDC exhibited large, outwardly rectifying currents and time-dependent inactivation at positive potential. The amplitude of the outward current was approximately 3 times of that of the inward current, and this volume-activated current returned to the baseline when switched to isotonic solution. The amplitude and reversal potential of the volume-activated current was dependent on Cl(-) concentration, and the VACC was significantly inhibited by replacing chloride with gluconate, glutamate, sucrose, and acetate in the hypotonic solution. In addition, classical VACC inhibitors, such as NPPB or tamoxifen, inhibited the VACC. These inhibitory effects were reversible with washing out the inhibitors from the bath solution. The present study is the first to characterize and show that HBDC has an intact RVD, mediated by VACC, which has similar electrophysiological characteristics as that in mouse cholangiocytes.
authors.affiliation: Department of Medicine, Division of Gastroenterology/Hepatology, Indiana University School of Medicine and The Richard L. Roudebush Veterans Affairs Medical Center, 1481 W 10th Street, Indianapolis, IN 46202, USA.
authors.forename: Biyi
authors.initials: B
authors.lastname: Chen
authors.forename: Douglas M
authors.initials: DM
authors.lastname: Jefferson
authors.forename: Won Kyoo
authors.initials: WK
authors.lastname: Cho
mesh_terms: D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D001652:Bile Ducts / Q000166:cytology* / Q000187:drug effects; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D018118:Chloride Channels / Q000187:drug effects / Q000502:physiology*; D002712:Chlorides / Q000378:metabolism*; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007038:Hypotonic Solutions / Q000494:pharmacology; D007552:Isotonic Solutions / Q000494:pharmacology; D009579:Nitrobenzoates / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D013629:Tamoxifen / Q000494:pharmacology
chemical_list: D018118:Chloride Channels; D002712:Chlorides; D007038:Hypotonic Solutions; D007552:Isotonic Solutions; D009579:Nitrobenzoates; D013629:Tamoxifen; C070379:1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester; C058176:5-nitro-2-(3-phenylpropylamino)benzoic acid; D004533:Egtazic Acid; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
references.citation: J Physiol. 1999 Mar 1;515 ( Pt 2):501-10
references.pmid: 10050016
references.citation: J Biol Chem. 2004 Apr 9;279(15):14610-8
references.pmid: 14722124
references.citation: Pflugers Arch. 2007 Nov;455(2):261-71
references.pmid: 17503070
references.citation: Gastroenterology. 1995 Feb;108(2):584-92
references.pmid: 7530672
references.citation: Am J Physiol. 1996 Aug;271(2 Pt 1):G239-48
references.pmid: 8770039
references.citation: Am J Physiol. 1994 Jun;266(6 Pt 1):G1060-70
references.pmid: 8023938
references.citation: Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1158-67
references.pmid: 15534373
references.citation: Hepatology. 1998 Jan;27(1):7-14
references.pmid: 9425910
references.citation: Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H130-8
references.pmid: 10899050
references.citation: J Gen Physiol. 1993 Jun;101(6):801-26
references.pmid: 7687269
references.citation: Physiol Rev. 1989 Apr;69(2):315-82
references.pmid: 2538851
references.citation: Acta Physiol Scand. 2003 Feb;177(2):119-47
references.pmid: 12558550
references.citation: J Physiol. 1988 Aug;402:687-702
references.pmid: 2466988
references.citation: Recept Channels. 1993;1(4):305-13
references.pmid: 7915949
references.citation: J Physiol. 1998 Dec 1;513 ( Pt 2):453-65
references.pmid: 9806995
references.citation: Am J Physiol Gastrointest Liver Physiol. 2002 Dec;283(6):G1320-7
references.pmid: 12433664
references.citation: J Clin Invest. 1993 Jan;91(1):319-28
references.pmid: 7678606
references.citation: J Membr Biol. 1992 Mar;126(3):219-34
references.pmid: 1378500
references.citation: Prog Biophys Mol Biol. 1997;68(1):69-119
references.pmid: 9481145
references.citation: J Membr Biol. 1997 Jul 1;158(1):1-16
references.pmid: 9211717
references.citation: Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6527-31
references.pmid: 7541542
references.citation: J Membr Biol. 2007 Jan;215(1):1-13
references.pmid: 17483866